BioPhausia AB (OMX:BIOP), a Swedish specialty pharmaceutical company, has retained Bourne Partners, a healthcare-focused merchant bank, as their exclusive financial advisor in an effort to identify marketing and distribution partners in the United States for RescueFlow® (7.5% sodium chloride and 6% dextran 70), the company’s novel Small Volume Resuscitation drug.
